FDA Proposes New, Easy-to-Read Medication Guide for Patients

May 31, 2023 by Dan McCue
FDA Proposes New, Easy-to-Read Medication Guide for Patients
(Photo by Riya via Pixabay)

WASHINGTON — The Food and Drug Administration wants to make it easier for patients to understand why they’ve been prescribed specific medications and how to ensure they don’t suffer any preventable adverse reactions when taking them.

Toward that end the agency has proposed requiring a new type of medication guide for prescription drugs and certain biological products.

The new Patient Medication Information guide will apply to both brand name and generic drugs used, dispensed or administered on an outpatient basis.

It will also include information for blood and blood components transfused in an outpatient setting.

“Providing people with accurate and timely information to help them take their prescription medications safely and effectively is an important priority for the Food and Drug Administration,” said FDA Commissioner Dr. Robert M. Califf, in a written statement.

“Evidence suggests that more easy-to-read information can help patients reduce preventable adverse drug reactions and improve health outcomes,” he said.

Unfortunately, Califf said, studies have found the current system for written information for prescription drugs and certain biological products can be confusing, conflicting, incomplete or repetitive. 

“When such critical information is difficult to understand, patients can become frustrated, stop taking their medications, or not take their medications as directed, which can be harmful to their health,” he said.

Califf’s statement is backed up by some sobering numbers. Researchers have found that taking medication in a way not prescribed by a doctor accounts for nearly 25% of all hospital admissions annually.

Such “nonadherence” to medication protocols has also led to treatment failures in about 50% of cases and approximately 125,000 deaths each year. 

“While medication nonadherence is complex, inconsistency with the existing types of written information for prescription drugs and certain biological products can negatively impact public health, and we are eager to fix it,” Califf said.

As outlined by the department, the proposed Patient Medication Information would provide patients with clear, concise, accessible and useful written information for prescription drugs and certain biological products and would be delivered in a consistent and easy-to-understand format to help patients use their prescription drugs and certain biological products safely and effectively. 

In addition, the FDA is hopeful that the Patient Medication Information’s consistent formatting may help facilitate translations to other languages and make it easier for artificial intelligence or other technologies to convert the information, where feasible, to formats that assist the visually impaired. 

These FDA-approved, one-page documents would highlight the essential information patients need to know in a standardized format, including:

  • Drug/Biological product name.
  • Concise summary of the indications and uses.
  • Important safety information.
  • Common side effects.
  • Directions for use.

Califf said the Patient Medication Information would be given to patients with their prescription drugs and certain biological products when provided in an outpatient setting and also be available online for the public to access. 

Comments on the proposal are being solicited through Nov. 27.

They can be submitted electronically at the federal eRulemaking Portal: https://www.regulations.gov, or in writing by mail or hand-delivery to Dockets Management Staff (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

Dan can be reached at [email protected] and at https://twitter.com/DanMcCue

A+
a-
  • Food and Drug Administration
  • generics
  • Patient Medication Information
  • prescription drugs
  • In The News

    Health

    Voting

    Prescription Drugs

    Biden and Harris Team Up for Health Care Event in North Carolina

    WASHINGTON (AP) — President Joe Biden and Vice President Kamala Harris will promote their health care agenda on Tuesday in... Read More

    WASHINGTON (AP) — President Joe Biden and Vice President Kamala Harris will promote their health care agenda on Tuesday in North Carolina, a battleground state that Democrats hope to flip in their favor after falling short to Donald Trump in the last two presidential elections. Fourteen... Read More

    March 13, 2024
    by Dan McCue
    FDA Believed Poised to Approve First Med for a Serious Liver Disease

    WASHINGTON — The Food and Drug Administration appears poised to approve the first medicine developed specifically to treat the serious... Read More

    WASHINGTON — The Food and Drug Administration appears poised to approve the first medicine developed specifically to treat the serious liver disease known as MASH later this week.  Metabolic dysfunction-associated steatohepatitis -- formerly known as nonalcoholic steatohepatitis — is often associated with obesity. In patients who... Read More

    March 6, 2024
    by Dan McCue
    Health Care, Drug Prices to Be Cornerstone of State of the Union

    WASHINGTON — President Joe Biden’s plans to do more to lower prescription drug prices and ensure the nation’s health care... Read More

    WASHINGTON — President Joe Biden’s plans to do more to lower prescription drug prices and ensure the nation’s health care system works better for more Americans will be the centerpiece of his State of the Union address, the White House revealed Wednesday. In a conference call... Read More

    March 4, 2024
    by Dan McCue
    Judge Rules Against Drugmaker in Price Negotiation Lawsuit

    WILMINGTON, Del. — A federal judge in Delaware ruled against the pharmaceutical and biotech company AstraZeneca last Friday in a... Read More

    WILMINGTON, Del. — A federal judge in Delaware ruled against the pharmaceutical and biotech company AstraZeneca last Friday in a case challenging the constitutionality of Medicare’s new drug negotiation program. The case is one of several filed by the pharmaceutical industry and its allies and the... Read More

    March 1, 2024
    by Dan McCue
    CVS, Walgreens to Begin Selling Abortion Pills Later This Month

    WASHINGTON — The nation’s two largest pharmacy chains will start dispensing the abortion pill mifepristone in select states later this... Read More

    WASHINGTON — The nation’s two largest pharmacy chains will start dispensing the abortion pill mifepristone in select states later this month, just weeks before the Supreme Court is set to hear a case that could lead to its removal from the market. The decision by both... Read More

    February 22, 2024
    by Dan McCue
    House Democrats Launch Inquiry Into Nationwide Drug Shortages

    WASHINGTON — Democrats on the House Committee on Oversight and Accountability are pressing some of the nation's largest drug manufacturers... Read More

    WASHINGTON — Democrats on the House Committee on Oversight and Accountability are pressing some of the nation's largest drug manufacturers for answers on why there are still intermittent and repeated shortages of cancer meds and other drugs. Led by Rep. Jamie Raskin, D-Md., the ranking member... Read More

    News From The Well
    scroll top